Company Filing History:
Years Active: 2010-2023
Title: Clive G Wilson: Innovator in Pharmaceutical Compositions
Introduction
Clive G Wilson is a notable inventor based in Glasgow, GB, recognized for his contributions to the field of pharmaceutical compositions. With a total of five patents to his name, Wilson has made significant advancements in the stability and effectiveness of bioactive polypeptides and proteins.
Latest Patents
Wilson's latest patents include innovative compositions that enhance the stability and shelf-life of bioactive polypeptides and proteins. One of his key inventions is a stabilized protein composition based on semifluorinated alkanes. This invention provides novel compositions that effectively protect polypeptides and proteins from degradation and aggregation. These compositions are particularly useful for topical administration, such as into the eye, or through parenteral injection, including subcutaneous or intramuscular routes. Another significant patent is a liquid pharmaceutical composition designed for the treatment of posterior eye diseases. This invention utilizes liquid vehicles with a density substantially higher than that of aqueous physiological fluids, making them effective medicines in ophthalmology. These compositions can be administered topically or through minimally invasive periocular injections, with preferred liquid carriers also being semifluorinated alkanes.
Career Highlights
Throughout his career, Clive G Wilson has worked with prominent organizations, including Novaliq GmbH and the University of London. His work has focused on developing innovative solutions that address critical challenges in the pharmaceutical industry.
Collaborations
Wilson has collaborated with notable professionals in his field, including Bernhard Günther and Bastian Theisinger. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Clive G Wilson's contributions to pharmaceutical compositions demonstrate his commitment to innovation and improving medical treatments. His patents reflect a deep understanding of the complexities involved in stabilizing bioactive compounds, ultimately benefiting the field of ophthalmology and beyond.